Dr. Rashida Alyia Abbas, MD

Dr. Abbas practices at Huntsville Hospital in Huntsville, Alabama, part of City of Huntsville, AL.

Dr. Abbas' NPI, 1811044605, was assigned on January 4, 2007. Dr. Abbas graduated from Perelman School of Med at the University of Pennsylvania in 1996. Dr. Abbas holds Alabama license 28490.

Dr. Abbas' primary practice is Huntsville Hospital, at 101 Sivley Rd, Huntsville, AL 35801 in Madison County. The practice phone is (256) 265-1000.

Dr. Abbas' primary practice is Huntsville Hospital in Huntsville, Alabama, part of City of Huntsville, AL. Dr. Abbas is also affiliated with Marshall Medical Center South. The medical group on file is The Heart Center. Dmand AI also links Dr. Abbas to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abbas practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Abbas' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Abbas is licensed in Alabama.

CMS data shows 2,137 Medicare services from Dr. Abbas across 20 procedure codes in 2024, for 693 Medicare patients. Medicare paid $82,480 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 693 Medicare patients who saw Dr. Abbas in 2024. The largest group is 75 to 84, with 272 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abbas' median patient age at 72, with 49% women.

In 2024, Dr. Abbas wrote 5,181 Medicare Part D claims for 537 patients. 76% of them were for generic drugs. CMS names the drug for 4,922 of them, across 46 drugs with 11 or more claims each, at $1,198,079 in total drug cost. In 2023, CMS named 4,150 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Abbas for performance year 2024, reported through an alternative payment model (APM). Dr. Abbas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 178 general payments to Dr. Abbas from 26 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 51% of the total. Abbott Laboratories paid the most, $3,288.

Dr. Abbas graduated from Perelman School of Med at the University of Pennsylvania in 1996.